A teaching protocol demonstrating the use of EasyClone and CRISPR/Cas9 for metabolic engineering of Saccharomyces cerevisiae and Yarrowia lipolytica

被引:8
|
作者
Milne, N. [1 ]
Tramontin, L. R. R. [1 ]
Borodina, I [1 ]
机构
[1] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, Kemitorvet 220, DK-2800 Lyngby, Denmark
基金
欧洲研究理事会; 欧盟地平线“2020”;
关键词
CRISPR/Cas9; EasyClone; metabolic engineering; Saccharomyces cerevisiae; Yarrowia lipolytica; beta-carotene; BETA-CAROTENE; YEAST; INTEGRATION; GENES; PATHWAY; ACID;
D O I
10.1093/femsyr/foz062
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
We present a teaching protocol suitable for demonstrating the use of EasyClone and CRISPR/Cas9 for metabolic engineering of industrially relevant yeasts Saccharomyces cerevisiae and Yarrowia lipolytica, using beta-carotene production as a case study. The protocol details all steps required to generate DNA parts, transform and genotype yeast, and perform a phenotypic screen to determine beta-carotene production. The protocol is intended to be used as an instruction manual for a two-week practical course aimed at M.Sc. and Ph.D. students. The protocol details all necessary steps for students to engineer yeast to produce beta-carotene and serves as a practical introduction to the principles of metabolic engineering including the concepts of boosting native precursor supply and alleviating rate-limiting steps. It also highlights key differences in the metabolism and heterologous production capacity of two industrially relevant yeast species. The protocol is divided into daily experiments covering a two-week period and provides detailed instructions for every step meaning this protocol can be used 'as is' for a teaching course or as a case study for how yeast can be engineered to produce value-added molecules.
引用
收藏
页数:15
相关论文
共 50 条
  • [41] Evaluation of Saccharomyces cerevisiae modified via CRISPR/Cas9 as a cellulosic platform microorganism in simultaneously saccharification and fermentation processes
    Allan H. F. de Mélo
    Alexia L. Nunes
    Priscila H. Carvalho
    Marcos F. da Silva
    Gleidson S. Teixeira
    Rosana Goldbeck
    Bioprocess and Biosystems Engineering, 2023, 46 : 1111 - 1119
  • [42] Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
    Ju, Hyemin
    Kim, Dongyoon
    Oh, Yu-Kyoung
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 17 (05) : 641 - 652
  • [43] CAR1 deletion by CRISPR/Cas9 reduces formation of ethyl carbamate from ethanol fermentation by Saccharomyces cerevisiae
    Chin, Young-Wook
    Kang, Woo-Kyung
    Jang, Hae Won
    Turner, Timothy L.
    Kim, Hyo Jin
    JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, 2016, 43 (11) : 1517 - 1525
  • [44] Modification of a Chlamydomonas reinhardtii CRISPR/Cas9 transformation protocol for use with widely available electroporation equipment
    Park, Rudolph, V
    Asbury, Holly
    Miller, Stephen M.
    METHODSX, 2020, 7
  • [45] Metabolic engineering of bacterial strains using CRISPR/Cas9 systems for biosynthesis of value-added products
    Fokum, Ernest
    Zabed, Hossain M.
    Guo, Qi
    Yun, Junhua
    Yang, Miaomiao
    Pang, Hao
    An, Yingfeng
    Li, Wen
    Qi, Xianghui
    FOOD BIOSCIENCE, 2019, 28 : 125 - 132
  • [46] Inducible promoters of bacterial microcompartments improve the CRISPR/Cas9 tools for efficient metabolic engineering of Clostridium ljungdahlii
    Zhang, Jun-Zhe
    Li, Yu-Zhen
    Xi, Zhi-Ning
    Zhang, Yue
    Liu, Zi-Yong
    Ma, Xiao-Qing
    Li, Fu-Li
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2025,
  • [47] Metabolic engineering of Escherichia coli BW25113 for the production of 5-Aminolevulinic Acid based on CRISPR/Cas9 mediated gene knockout and metabolic pathway modification
    Changchuan Ye
    Yuting Yang
    Xi Chen
    Lijie Yang
    Xia Hua
    Mengjie Yang
    Xiangfang Zeng
    Shiyan Qiao
    Journal of Biological Engineering, 16
  • [48] The Use of CRISPR/Cas9 Technology in Engineering Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for the Treatment of Cancer in Brazil
    Carvalho, Julia
    Cupello, Mauricio
    Medina, Romulo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S525 - S526
  • [49] Metabolic engineering of Aspergillus niger via ribonucleoprotein-based CRISPR–Cas9 system for succinic acid production from renewable biomass
    Lei Yang
    Mikkel Møller Henriksen
    Rasmus Syrach Hansen
    Mette Lübeck
    Jesper Vang
    Julie Egelund Andersen
    Signe Bille
    Peter Stephensen Lübeck
    Biotechnology for Biofuels, 13
  • [50] Enhancement of galactose consumption rate in Saccharomyces cerevisiae CEN. PK2-1 by CRISPR Cas9 and adaptive evolution for fermentation of Kappaphycus alvarezii hydrolysate
    Sunwoo, In Yung
    Sukwong, Pailin
    Jeong, Deok Yeol
    Kim, Soo Rin
    Jeong, Gwi-Teak
    Kim, Sung-Koo
    JOURNAL OF BIOTECHNOLOGY, 2019, 297 : 78 - 84